Share
Sglt2 Inhibitors: Effects on Cardioprotection
Mourad Boukheloua
(Author)
·
Souad Chelghoum
(Author)
·
Ourida Gacem
(Author)
·
Our Knowledge Publishing
· Paperback
Sglt2 Inhibitors: Effects on Cardioprotection - Boukheloua, Mourad ; Chelghoum, Souad ; Gacem, Ourida
Choose the list to add your product or create one New List
✓ Product added successfully to the Wishlist.
Go to My Wishlists
Origin: U.S.A.
(Import costs included in the price)
It will be shipped from our warehouse between
Friday, June 07 and
Tuesday, June 25.
You will receive it anywhere in United Kingdom between 1 and 3 business days after shipment.
Synopsis "Sglt2 Inhibitors: Effects on Cardioprotection"
Sodium-glucose cotransporter 2 (SGLT2) inhibitors, initially developed as anti-hyperglycemic drugs, have been shown to significantly improve metabolic indicators and protect the kidneys and hearts of patients with and without type 2 diabetes. The possible mechanisms for these benefits are the subject of extensive research, as they cannot be attributed solely to improved blood sugar control. In this book, we will focus on the current understanding of cardio-renal protection by SGLT2 inhibitors by explaining the pathophysiological mechanisms involved, and we will present the largest trials that have demonstrated this organoprotective effect.
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.
✓ Producto agregado correctamente al carro, Ir a Pagar.
